Bernard Horowitz serves as Executive at Omrix Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Bernard Horowitz has executed 9 insider transactions totaling $108.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 4, 2008 involved receiving (via award) 2,000 shares valued at $0.
Bernard Horowitz currently holds 10,467 shares of Omrix Biopharmaceuticals, Inc. (OMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bernard Horowitz has been a net seller of OMRI stock. They have purchased $39.0K and sold $69.0K worth of shares.
Bernard Horowitz's most recent insider trade was on Sep 4, 2008, when they sold 2,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $12.27 |
| Discretionary |
| Jun 6, 2007 | OMRI | $27.2K | Option Exercise | 2,717 | $10.00 | Discretionary |
| Jun 5, 2007 | OMRI | $69.0K | Sale | 2,000 | $34.50 | Discretionary |
| May 31, 2007 | OMRI | $0 | Award | 2,000 | $N/A | Discretionary |
| Nov 20, 2006 | OMRI | $0 | Gift | 1,000 | $N/A | Discretionary |
| May 16, 2006 | OMRI | $14.2K | Purchase | 1,000 | $14.20 | Discretionary |
| May 15, 2006 | OMRI | $14.6K | Purchase | 1,000 | $14.57 | Discretionary |
| Apr 24, 2006 | OMRI | $10.2K | Purchase | 1,000 | $10.24 | Discretionary |